For Pennsylvania health-insurance denials
State · Pennsylvania · appeal letter

How to appeal a denied claim in Pennsylvania.

Pennsylvania is one of the largest insured states in the Northeast, and the appeal-rights framework here has its own scaffolding anchored in the Pennsylvania Insurance Department (PID) under the Managed Care Plan Consumer Protection Act at 40 P.S. § 991d.117B et seq., the statutory external-review pathway at 40 P.S. § 117B.4 with a 4-month filing window from the carrier's final internal Adverse Benefit Determination, the Utilization Review (UR) and carrier-issued ABD procedure in 31 Pa. Code Chapter 89 (with UR-agent standards at 31 Pa. Code § 89.44), and the federal ERISA § 503 procedure at 29 C.F.R. § 2560.503-1 for self-funded employer plans operating in Pennsylvania. A Pennsylvania ADVERSE BENEFIT DETERMINATION carries the same EOB reason codes a denial in any other state would — "medical necessity not established," "not a covered benefit," "precertification not obtained," "step-therapy criteria not satisfied," "out-of-network provider," "prescription drug not on formulary" — but the appeal frameworks that attach are Pennsylvania-specific, the home-state BCBS affiliates that shape the PA market are Highmark (western PA), Capital BlueCross (central PA) and Independence Blue Cross / IBC (southeastern PA — Philadelphia), and the PA-specific issuers — UPMC Health Plan (Pittsburgh region) and Geisinger Health Plan / Geisinger Quality Options (central / north-central PA) — round out the regional carrier mix alongside the mainstream commercial carriers (Aetna, Cigna, Humana, UnitedHealthcare). The agency that intervenes is the Pennsylvania Insurance Department Consumer Services Bureau at 1-877-881-6388 (pid.pa.gov), and the timelines are a 21-day internal review window under 40 P.S. § 991d.117B.2, a 4-month statutory external review (IRO) window under 40 P.S. § 117B.4, and a 72-hour expedited review under the federal ERISA § 503 urgent-claim framing for self-funded employer plans. Self-funded employer plans under the federal ERISA § 503 procedure at 29 C.F.R. § 2560.503-1 still apply, but the PID complaint pathway under 40 P.S. § 117B and the statutory external-review channel at § 117B.4 do not govern self-funded ERISA groups.

01 · What this segment looks like

A Pennsylvania health-insurance denial — and the appeal frameworks that apply to it.

The Pennsylvania denial segment captures a specific configuration: the member holds a fully-insured PID-licensed plan issued in Pennsylvania, with the dominant home-state BCBS affiliates (Highmark Blue Cross Blue Shield / Highmark Blue Shield for western PA, Capital BlueCross for central PA, Independence Blue Cross / IBC for the Philadelphia / southeastern PA region), the PA-specific integrated issuers (UPMC Health Plan in the Pittsburgh region, Geisinger Health Plan / Geisinger Quality Options in central / north-central PA), and the mainstream commercial carriers — Aetna, Cigna, Humana, UnitedHealthcare — operating PID-licensed fully-insured PPO/EPO products in PA. The denial reason will track the carrier's internal reason code (medical necessity, prior authorization, step therapy, formulary exclusion, out-of-network), but the appeal frameworks that attach are Pennsylvania-specific. The Pennsylvania Insurance Department (PID) regulates carriers under the Managed Care Plan Consumer Protection Act at 40 P.S. § 991d.117B et seq. — with § 117B.2 spelling out the carrier's standards for prompt investigation and payment of claims and the 21-day internal-review window keyed to the ABD, and § 117B.4 supplying the statutory external-review pathway (4-month filing window from the final internal ABD with the IRO list maintained by PID). The UR-agent standards under 31 Pa. Code § 89.44 govern utilization-review agent qualifications, clinical-criteria disclosure, and peer-reviewer escalation on utilization-review denials. The PID Consumer Services Bureau at 1-877-881-6388 and pid.pa.gov are the front door for Pennsylvania members.

PID-licensed carriers operating in Pennsylvania — Highmark (western PA), Capital BlueCross (central PA), Independence Blue Cross / IBC (southeastern PA), UPMC Health Plan, Geisinger Health Plan, Aetna, Cigna, Humana, UnitedHealthcare's fully-insured PA products — are subject to 40 P.S. § 991d.117B.2 et seq. and 40 P.S. § 117B.4, with the UR-agent standards under 31 Pa. Code Ch. 89 (and § 89.44 specifically) layering on top: a 21-day internal-review window from the ABD under § 117B.2, a 4-month statutory external review (IRO) window from the final internal ABD under § 117B.4 with the IRO list maintained by PID, and the UR-agent standards under 31 Pa. Code § 89.44 governing UR-agent qualifications, clinical-criteria disclosure, and peer-reviewer escalation. The PID complaint pathway under 40 P.S. § 117B and the § 117B.4 statutory external review channel run in parallel with the federal 4-month ACA external-review window at 45 C.F.R. § 147.136(d) for ACA marketplace plans operating in Pennsylvania, and the most protective of the two carries the day.

Self-funded ERISA plans — the typical larger-employer group plan where the employer pays the claims rather than buying insurance from a carrier — fall outside PID jurisdiction and outside 40 P.S. § 117B.4, and run through the federal ERISA § 503 claims-procedure rule at 29 C.F.R. § 2560.503-1, with the 4-month federal external-review channel at 29 C.F.R. § 2590.715-2719 for non-grandfathered plans and ERISA § 502(a) civil action at 29 U.S.C. § 1132(a)(1)(B) as the post-exhaustion remedy. Pennsylvania UR laws (31 Pa. Code Ch. 89; § 89.44 specifically) still apply to procedural aspects the federal rule does not preempt — UR-agent qualifications, clinical-criteria disclosure, peer-reviewer escalation — but the appeals timeline and the right-to-file-a-civil-action follow fully from 29 C.F.R. § 2560.503-1 and ERISA § 502(a). A well-built Pennsylvania appeal letter cites both: the controlling PA statute (40 P.S. § 117B.2 / 40 P.S. § 117B.4 for PID-licensed plans, plus 31 Pa. Code Ch. 89 / § 89.44 for the UR framework) or the federal preemption fallback (29 C.F.R. § 2560.503-1 for self-funded ERISA), and the right federal framework underneath.

01 · PA-specific timelines

01

21-day internal-review window

After an Adverse Benefit Determination on a PID-licensed Pennsylvania plan, the enrollee has 21 days from receipt of the ABD notice to file a first-stage internal review with the carrier under 40 P.S. § 991d.117B.2. The carrier then has 30 days to issue a decision for standard appeals, with the right to escalate to a PID complaint on exhaustion. The UR-agent standards at 31 Pa. Code § 89.44 govern the carrier's UR agent — qualifications, clinical-criteria disclosure, and the right to peer-reviewer escalation at the member's request. For non-PID self-funded ERISA plans, 29 C.F.R. § 2560.503-1(h)(3)(i) supplies the parallel federal window keyed to the ABD notice, and the PID complaint pathway is not available.

02

4-month statutory external review (IRO) window

After exhausting the carrier's internal review and receiving a final internal ABD, the enrollee has 4 months to file a statutory external review (IRO) request with the Pennsylvania Insurance Department under 40 P.S. § 117B.4, with the IRO list maintained by PID. Once the IRO is assigned, the IRO decision is binding on the carrier: when the IRO physician reviewer overturns the denial, the carrier must comply. The PID Consumer Services Bureau at 1-877-881-6388 and pid.pa.gov are the front door for both the initial complaint and the § 117B.4 statutory external review (IRO) request — the typical complaint-to-IRO cycle runs 30 to 45 calendar days for non-expedited reviews.

03

72-hour ERISA § 503 expedited (self-funded) / 24-hour § 117B.4 (urgent care)

Where a delay would seriously jeopardize the enrollee's life, health, or ability to regain maximum function, the expedited channels on PA plans collapse to the 72-hour federal ERISA § 503 urgent-claim framing under 29 C.F.R. § 2560.503-1(f)(2) for self-funded PA employer plans, or to the parallel federal 72-hour urgent external-review window at 45 C.F.R. § 147.136(e)(3) for ACA marketplace plans on the second-stage level. For PID-licensed fully-insured PA plans, the § 117B.4 statutory external review pathway attaches when a delay would jeopardize care, with the IRO list maintained by PID handling the expedited review. The appeal letter should frame the request as a continuation of an established clinical plan, not a new request, to put the expedited window on the table.

01 · PA-licensed carriers

Statutory external review (IRO) through the Pennsylvania Insurance Department — Consumer Services Bureau phone 1-877-881-6388 or the complaint intake form at pid.pa.gov.

PA

UnitedHealthcare

Member portal·myuhc.com

Appeals fax·(verify on EOB)

UnitedHealthcare's Pennsylvania membership runs through both PID-licensed fully-insured products and self-funded ERISA employer group plans. For fully-insured enrollees the appeal routes through the myuhc.com member portal, then escalates to a PID Consumer Services Bureau complaint at 1-877-881-6388 (pid.pa.gov) under 40 P.S. § 991d.117B et seq., with a 4-month statutory external review (IRO) deadline under 40 P.S. § 117B.4. For self-funded ERISA enrollees, the federal procedure at 29 C.F.R. § 2560.503-1 governs and the PID complaint pathway is not available.

01 · PA-licensed carriers

PID-licensed for fully-insured PA products; self-funded ERISA plans fall outside the PID complaint pathway.

Timelines

21-day internal · 4-month external (40 P.S. § 117B.4) · 72-hour ERISA urgent (self-funded)

PA

Aetna

Member portal·aetna.com member secure inbox

Appeals fax·1-860-975-1526

Aetna operates PID-licensed fully-insured PPO/EPO products in Pennsylvania. Aetna enrollees route appeals through the aetna.com member portal, then escalate to a PID Consumer Services Bureau complaint under 40 P.S. § 991d.117B et seq. and statutory external review (IRO) under 40 P.S. § 117B.4 within 4 months of the final internal ABD. The ACA-mandated 1-860-975-1526 appeals fax is available.

01 · PA-licensed carriers

PID-licensed for fully-insured PPO/EPO products; ERISA § 503 for self-funded group plans.

Timelines

21-day internal · 4-month IRO (PID) · 4-month external (ERISA self-funded)

PA

Blue Cross Blue Shield

Member portal·BCBS state portal

Appeals fax·(verify on EOB)

Blue Cross and Blue Shield in Pennsylvania is a federation of three home-state BCBS affiliates — Highmark Blue Cross Blue Shield / Highmark Blue Shield (western PA), Capital BlueCross (central PA), and Independence Blue Cross / IBC (Philadelphia / southeastern PA) — each PID-licensed for fully-insured PA products under 40 P.S. § 991d.117B et seq. The BCBS-PA affiliates effectively shape the PA appeal-rights framework. Appeals route through the home-state BCBS-PA member portal (Highmark: highmark.com / highmarkblueshield.com; Capital BlueCross: capitalbluecross.com; Independence Blue Cross: ibx.com), then escalate to a PID Consumer Services Bureau complaint at 1-877-881-6388 (pid.pa.gov) under § 117B.4, with a 4-month statutory external review (IRO) window.

01 · PA-licensed carriers

PID-licensed home-state BCBS affiliates (Highmark, Capital BlueCross, Independence Blue Cross / IBC).

Timelines

21-day internal · 4-month IRO (PID) · 4-month external (ERISA self-funded)

PA

Cigna

Member portal·mycigna.com

Appeals fax·(verify on EOB)

Cigna operates PID-licensed fully-insured PPO/EPO products in Pennsylvania. Cigna enrollees route appeals through mycigna.com, then escalate to a PID Consumer Services Bureau complaint under 40 P.S. § 991d.117B et seq. and statutory external review (IRO) under 40 P.S. § 117B.4. Self-funded ERISA plans through Cigna fall under 29 C.F.R. § 2560.503-1, and the PID complaint pathway under 40 P.S. § 117B is not available.

01 · PA-licensed carriers

PID-licensed for fully-insured PPO/EPO products; ERISA § 503 for self-funded employer plans.

Timelines

21-day internal · 4-month IRO (PID) · 4-month external (ERISA self-funded)

PA

Humana

Member portal·myhumana.com

Appeals fax·1-502-508-9301

Humana operates PID-licensed fully-insured PPO/EPO and Medicare Advantage plans in Pennsylvania. Humana enrollees route appeals through myhumana.com, then escalate to a PID Consumer Services Bureau complaint under 40 P.S. § 991d.117B et seq. and statutory external review (IRO) under 40 P.S. § 117B.4 within 4 months of the final internal ABD. The ACA-mandated 1-502-508-9301 appeals fax is available. Self-funded ERISA group plans through Humana fall under 29 C.F.R. § 2560.503-1.

01 · PA-licensed carriers

PID-licensed for fully-insured PPO/EPO products; ERISA § 503 for self-funded group plans.

Timelines

21-day internal · 4-month IRO (PID) · 4-month external (ERISA self-funded)

PA

Kaiser Permanente

Member portal·kp.org member account

Appeals fax·(verify on EOB)

Kaiser Permanente has a limited Pennsylvania presence (operating primarily in CA, CO, GA, HI, MD, OR, VA, WA — not a major Pennsylvania fully-insured-issuer). Most PA Kaiser enrollees are self-funded ERISA employer group plans under 29 C.F.R. § 2560.503-1, not PID-governed. The published Member Grievance & Appeals line at 1-800-464-4000 routes to the appropriate regional appeals office. The PID complaint pathway under 40 P.S. § 117B and the § 117B.4 statutory external review channel are not available on the typical PA employer plan.

01 · PA-licensed carriers

Limited PA-licensed presence; most PA enrollees are self-funded ERISA groups under 29 C.F.R. § 2560.503-1.

Timelines

21-day internal (Kaiser regional) · 4-month external (ERISA self-funded)

PA

Anthem (Elevance)

Member portal·anthem.com

Appeals fax·1-855-634-4652

Anthem Blue Cross and Blue Shield operates through Elevance Health, primarily in non-PA states (CA, NY, GA, OH, VA, IN, KY, MO, WI, CT, CO, NV, NH, ME). Pennsylvania Anthem enrollees are uncommon; most PA Blue Cross enrollees receive coverage through the home-state BCBS-PA affiliates (Highmark / Capital BlueCross / Independence Blue Cross / IBC) under PID jurisdiction. The Anthem-published Letter Review / Appeals fax at 1-855-634-4652 routes through the federal mandate. Self-funded ERISA plans through Anthem fall under 29 C.F.R. § 2560.503-1, and PID jurisdiction does not extend to Anthem ERISA group plans operating in PA.

01 · PA-licensed carriers

PA Anthem enrollees uncommon; most PA Blue Cross members route through Highmark / Capital BlueCross / IBC. Anthem ERISA plans fall under 29 C.F.R. § 2560.503-1.

Timelines

21-day internal (BCBS-PA or Anthem regional) · 4-month IRO (PID) · 4-month external (ERISA self-funded)

PA

Centene

Member portal·plan-specific member portal

Appeals fax·(verify on EOB)

Centene's Pennsylvania products include PA Health & Wellness (Pennsylvania Medicaid managed care) and Ambetter from PA Health & Wellness (ACA marketplace). Pennsylvania Medicaid managed-care appeals operate under DHS and the federal Medicaid managed-care appeals at 42 C.F.R. § 431 Subpart E; Ambetter ACA plans operate under the federal 45 C.F.R. § 147.136 framework. Centene's commercial PID-regulated products route through the corporate Member Appeals address at PO Box 2560, Farmington, MO 63640-2560 plus the plan-specific portal.

01 · PA-licensed carriers

PA Health & Wellness PA Medicaid + Ambetter PA Marketplace; DHS for managed-care; ACA at 45 C.F.R. § 147.136 for ACA; ERISA § 503 for self-funded employer groups.

Timelines

21-day internal (Centene commercial) · 4-month IRO (PID) · PA Medicaid DHS framework · 4-month external (ERISA self-funded)

PA

Molina Healthcare

Member portal·my Molina member portal

Appeals fax·(verify on EOB)

Molina Healthcare operates Pennsylvania Medicaid managed-care plans under the DHS framework and the federal Medicaid managed-care appeals at 42 C.F.R. § 431 Subpart E. Molina Medicaid enrollees in Pennsylvania have parallel state fair-hearing rights under the state Medicaid contract. Molina commercial PID-regulated products (rare in PA) route to a PID Consumer Services Bureau complaint under 40 P.S. § 991d.117B et seq. and statutory external review (IRO) under 40 P.S. § 117B.4. Self-funded ERISA groups fall under 29 C.F.R. § 2560.503-1.

01 · PA-licensed carriers

DHS / PA Medicaid managed-care for Medicaid enrollees; PID (§ 117B.4) for any commercial PPO/EPO; ERISA § 503 for self-funded groups.

Timelines

21-day internal (Molina commercial) · 4-month IRO (PID) · PA Medicaid DHS framework · 4-month external (ERISA self-funded)

01 · The three PA-specific denial shapes we see most

The timelines and review rights that apply on a Pennsylvania denial.

  • 01

    Highmark imaging or precertification denial (western PA)

    A Highmark Blue Cross Blue Shield (western PA) enrollee whose plan denied an MRI, CT, or surgery precertification on "medical necessity not established" or "precertification not obtained" grounds. Highmark is the home-state BCBS affiliate for western PA and a PID-licensed carrier for fully-insured PA products under 40 P.S. § 991d.117B et seq. — the appeal routes through the Highmark member portal, then escalates to a PID complaint at 1-877-881-6388 (pid.pa.gov) under § 117B.4, then reaches statutory external review (IRO) within 4 months of the final internal ABD. The appeal cites 40 P.S. § 991d.117B.2 for the 21-day internal-review window and 31 Pa. Code § 89.44 for the UR-agent standards.

  • 02

    Independence Blue Cross medical-necessity denial (southeastern PA)

    An Independence Blue Cross / IBC (Philadelphia / southeastern PA) enrollee whose carrier denied a service on "medical necessity not established," "experimental / investigational," or "not a covered benefit" grounds. IBC is the home-state BCBS affiliate for the Philadelphia region and PID-licensed for fully-insured PA products. The 21-day internal review under 40 P.S. § 991d.117B.2 routes through the IBC member portal, then escalates to a PID complaint and statutory external review (IRO) under 40 P.S. § 117B.4 within 4 months of the final internal ABD. Self-funded ERISA plans through IBC fall under 29 C.F.R. § 2560.503-1 with the parallel federal 4-month external-review window at 29 C.F.R. § 2590.715-2719.

  • 03

    UPMC Health Plan step-therapy denial (Pittsburgh / western PA)

    A UPMC Health Plan enrollee (the PA-specific integrated issuer serving the Pittsburgh region) whose plan denied a step-therapy exception or formulary exclusion on a biologic or specialty drug. UPMC operates PID-licensed fully-insured PA products in PA and self-funded ERISA employer plans through the larger-employer group market in PA. The denial routes through the UPMC member portal, then escalates through 40 P.S. § 117B.2 for fully-insured PID-licensed plans, or 29 C.F.R. § 2560.503-1 for self-funded ERISA. For ACA marketplace plans, the federal 4-month external-review channel under 45 C.F.R. § 147.136(d) attaches on the second-stage level. The appeal cites 31 Pa. Code § 89.44 to put the UR-agent peer-reviewer escalation on the record.

02 · Frequently asked

Three questions a Pennsylvania member typically has before drafting an appeal — with the PID Consumer Services Bureau at 1-877-881-6388, the § 117B.4 statutory external review IRO window, the 31 Pa. Code Ch. 89 UR framework, and the ERISA § 503 fallback for self-funded employer plans attached to each answer.

Top denial reasons in this state

Four denial reasons we see most in this state.

Each denial reason has its own appeal framework — pick the one that matches your EOB to land on the counter-argument, the cited framework, and the published submission channel that applies.

03 · Submit the Pennsylvania denial

The same denial — defended with the PA-specific adverse-determination framework.

Upload the most recent denial letter or EOB, answer the four short intake questions, and Denvow picks the Pennsylvania Insurance Department Consumer Services Bureau pathway under 40 P.S. § 991d.117B et seq. for PID-licensed Pennsylvania plans, the statutory external-review (IRO) path under 40 P.S. § 117B.4 for the 4-month statutory external review, the UR-agent standards under 31 Pa. Code Ch. 89 / § 89.44 for the UR framework, or the federal ERISA § 503 procedure at 29 C.F.R. § 2560.503-1 for self-funded employer plans operating in Pennsylvania — and the letter branches on whether you're at the 21-day internal review or the 4-month § 117B.4 statutory external review window.

Already in the intake? Pre-selected to "PA Pennsylvania" in the State field on the form — answer the rest of the four questions and submit. If your plan is self-funded ERISA, the intake sets the federal ERISA § 503 path automatically. If you're on a Highmark (western PA), Capital BlueCross (central PA), Independence Blue Cross / IBC (southeastern PA), UPMC Health Plan, or Geisinger Health Plan product, the script keys off the carrier name and routes to the appropriate PA-specific channel.

Denvow is template-and-tooling, not legal counsel. For denials that genuinely need litigation, an ERISA fiduciary complaint, or a state-court remedy, we recommend a licensed attorney in the relevant jurisdiction — and will say so when we see one.